To the Editor: An 80 kg, 73-year-old man with type 2 diabetes managed with gliclazide and metformin was discharged on a dose of 40 mg twice daily of sotalol and a therapeutic dose of warfarin after an admission for atrial flutter. Transoesophageal echocardiography during his admission showed normal left ventricular (LV) size with mild to moderate global systolic dysfunction and moderate mitral incompetence.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Yorgun H, Deniz A, Aytemir K. Cardiogenic shock secondary to combination of diltiazem and sotalol. Intern Med J 2008; 38: 221-222.
- 2. Leaver SK, Ho TB. Inadvertent toxic drug reaction in the management of atrial fibrillation. J R Soc Med 2006; 99: 149-150.
- 3. Therapeutic Goods Administration. Product information, Cardol (sotalol hydrochloride). Most recent amendment, 2013. https://www.ebs. tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-04535-3 (accessed May 2013).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.